KalVista Pharmaceuticals Announces the Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters’ Over-allotment Option to Purchase Additional Shares September 10, 2018
Verastem Oncology Announces Investigator Sponsored Study on Duvelisib in Combination with Venetoclax September 6, 2018
ArcherDX Names Former Foundation Medicine Executive Steven Kafka, Ph.D. to its Board of Directors September 5, 2018
